March 20, 2025
TOPLINE: Poor outcomes in patients with cutaneous squamous cell carcinoma (CSCC) were more likely if they had additional risk factors, a multinational study found. METHODOLOGY: A […]
March 18, 2025
ORLANDO, Fla. — Adolescents with severe or very severe alopecia areata (AA) were able to regrow hair, some with a 90% improvement in hair loss, after […]
March 18, 2025
The US Food and Drug Administration (FDA) has identified a limited number of benzoyl peroxide (BPO) acne products for retail-level recall because of elevated benzene levels, […]
March 18, 2025
ORLANDO, Fla. — In a phase 3 atopic dermatitis (AD) trial, rocatinlimab, a novel therapy that targets T cells expressing the OX40 receptor, showed efficacy on […]
March 17, 2025
ORLANDO, Fla. — Adults with moderate to severe plaque psoriasis taking the novel oral drug icotrokinra had significant improvement starting at week 16, with increased response […]
March 17, 2025
ORLANDO, Fla. — The topical Janus tyrosine kinase (JAK) 1/2 inhibitor ruxolitinib improved itching and nodules in patients with prurigo nodularis (PN) significantly better than a […]
March 14, 2025
Edited By: Deepa Varma TOPLINE: Mohs micrographic surgery (MMS) outperforms conventional excision (CE) in patients with hand and foot melanomas, a retrospective cohort study finds. METHODOLOGY: […]
March 13, 2025
ORLANDO, Fla. — The interleukin (IL)-4 and IL-13 inhibitor dupilumab improved itch symptoms and curtailed disease activity while also reducing oral corticosteroid use in older patients […]
March 13, 2025
TOPLINE: Shared inflammatory signatures in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome, myelodysplasia cutis (MDS-cutis), and Sweet syndrome (SS) suggest interferon pathways as therapeutic targets. […]